{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:50:42Z","timestamp":1791942642576,"version":"4.3.4"},"reference-count":78,"publisher":"Harborside Press, LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Cancer center accreditation status is predicated on several factors that measure high-value healthcare. However, price transparency, which is critical in healthcare decisions, is not a quality measure included for accreditation. We reported the rates of price disclosure of surgical procedures for 5 cancers (breast, lung, cutaneous melanoma, colon, and prostate) among hospitals ranked by the American College of Surgeon\u2019s Commission on Cancer (ACS-CoC). <jats:bold>Methods:<\/jats:bold> We identified nonfederal, adult, and noncritical access ACS-CoC accredited hospitals and used the commercial Turquoise Health database to perform a cross-sectional analysis of hospital price disclosures for 5 common oncologic procedures (mastectomy, lobectomy, wide local excision for cutaneous melanoma, partial colectomy, prostatectomy). Publicly available financial reporting data were used to compile facility-specific features, including bed size, teaching status, Centers for Medicare &amp; Medicaid wage index, and patient revenues. Modified Poisson regression evaluated the association between price disclosure and ACS-CoC accreditation after adjusting for hospital financial performance. <jats:bold>Results:<\/jats:bold> Of 1,075 total ACS-CoC accredited hospitals, 544 (50.6%) did not disclose prices for any of the surgical procedures and only 313 (29.1%) hospitals reported prices for all 5 procedures. Of the 5 oncologic procedures, prostatectomy and lobectomy had the lowest price disclosure rates. Disclosing and nondisclosing hospitals significantly differed in ACS-CoC accreditation, ownership type, and teaching status. Hospitals that disclosed prices were more likely to receive Medicaid disproportionate share hospital payments, have lower average charge to cost ratios (4.53 vs 5.15; <jats:italic>P<\/jats:italic>&lt;.001), and have lower net hospital margins (\u22122.03 vs 0.44; <jats:italic>P<\/jats:italic>=.005). After adjustment, a 1-point increase in markup was associated with a 4.8% (95% CI, 2.2%\u20137.4%; <jats:italic>P<\/jats:italic>&lt;.001) higher likelihood of nondisclosure. <jats:bold>Conclusions:<\/jats:bold> More than half of the hospitals did not disclose prices for any of the 5 most common oncologic procedures despite ACS-CoC accreditation. It remains difficult to obtain price transparency for common oncologic procedures even at centers of excellence, signaling a discordance between quality measures visible to patients.<\/jats:p>","DOI":"10.6004\/jnccn.2022.7057","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T21:05:46Z","timestamp":1668027946000},"page":"1215-1222.e1","source":"Crossref","is-referenced-by-count":4,"title":["Association Between Cancer Center Accreditation and Compliance With Price Disclosure of Common Oncologic Surgical Procedures"],"prefix":"10.6004","volume":"20","author":[{"given":"Yuqi","family":"Zhang","sequence":"first","affiliation":[{"name":"1National Clinician Scholars Program, Duke University, Durham, North Carolina;"},{"name":"2Department of Surgery, Yale University, New Haven, Connecticut;"},{"name":"3Durham Veterans Affairs, Durham, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Cerullo","sequence":"additional","affiliation":[{"name":"1National Clinician Scholars Program, Duke University, Durham, North Carolina;"},{"name":"3Durham Veterans Affairs, Durham, North Carolina;"},{"name":"4Department of Surgery, Duke University, Durham, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Esposito","sequence":"additional","affiliation":[{"name":"2Department of Surgery, Yale University, New Haven, Connecticut;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnukamal","family":"Golla","sequence":"additional","affiliation":[{"name":"1National Clinician Scholars Program, Duke University, Durham, North Carolina;"},{"name":"3Durham Veterans Affairs, Durham, North Carolina;"},{"name":"5Department of Surgery, Division of Urology, and"},{"name":"6Margolis Center for Health Policy, Duke University, Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"ref351","article-title":"Factors associated with compliance to the hospital price transparency final rule: a national landscape study","author":"Jiang","journal-title":"J Gen Intern Med"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jso.25605","article-title":"Financial toxicity risk among adult patients undergoing cancer surgery in the United States: an analysis of the National Inpatient Sample","volume":"120","author":"Farooq","year":"2019","journal-title":"J Surg Oncol"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamasurg.2021.0590","article-title":"Analysis of price transparency for oncologic surgery among National Cancer Institute-designated cancer centers in 2020","volume":"156","author":"Xiao","year":"2021","journal-title":"JAMA Surg"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jamaophthalmol.2021.3951","article-title":"Health care price transparency in ophthalmology","volume":"139","author":"Berkowitz","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/MLR.0b013e31819c95aa","article-title":"Administrative and claims records as sources of health care cost data","volume":"47","author":"Riley","year":"2009","journal-title":"Med Care"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.euo.2021.02.007","article-title":"Financial toxicity among patients with prostate, bladder, and kidney cancer: a systematic review and call to action","volume":"4","author":"Bhanvadia","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jaad.2020.08.048","article-title":"Chargemasters and price transparency in dermatology","volume":"85","author":"Zurfley","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"ref951","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1475-6773.2010.01082.x","article-title":"Long-term trends in Medicare payments in the last year of life","volume":"45","author":"Riley","year":"2010","journal-title":"Health Serv Res"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s11606-011-1815-5","article-title":"The association between hospital margins, quality of care, and closure or other change in operating status","volume":"26","author":"Ly","year":"2011","journal-title":"J Gen Intern Med"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/1556331621991825","article-title":"A review of price transparency policy and evaluation of hospital compliance in orthopedic sports medicine","volume":"17","author":"Schultz","year":"2021","journal-title":"HSS J"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1001\/jama.2021.4640","article-title":"Price transparency\u2014promise and peril","volume":"325","author":"Glied","year":"2021","journal-title":"JAMA"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jaad.2020.08.048","article-title":"Chargemasters and price transparency in dermatology","volume":"85","author":"Zurfley","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"ref811","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/jama.2021.8535","article-title":"Payer-negotiated prices in the diagnosis and management of thyroid cancer in 2021","volume":"326","author":"Xiao","year":"2021","journal-title":"JAMA"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jamaophthalmol.2021.3951","article-title":"Health care price transparency in ophthalmology","volume":"139","author":"Berkowitz","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1001\/jama.2017.5702","article-title":"Association between teaching status and mortality in US hospitals","volume":"317","author":"Burke","year":"2017","journal-title":"JAMA"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamaoncol.2019.5690","article-title":"Analysis of price transparency via National Cancer Institute-Designated Cancer Centers\u2019 chargemasters for prostate cancer radiation therapy","volume":"6","author":"Agarwal","year":"2020","journal-title":"JAMA Oncol"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"e2110109","DOI":"10.1001\/jamanetworkopen.2021.10109","article-title":"Transparency, accessibility, and variability of US hospital price data","volume":"4","author":"Haque","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"e2137566","DOI":"10.1001\/jamanetworkopen.2021.37566","article-title":"Considering the future of price transparency initiatives-information alone is not sufficient","volume":"4","author":"Emanuel","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/0962280211427759","article-title":"Extension of the modified Poisson regression model to prospective studies with correlated binary data","volume":"22","author":"Zou","year":"2013","journal-title":"Stat Methods Med Res"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1377\/hlthaff.2015.1193","article-title":"A more detailed understanding of factors associated with hospital Profitability","volume":"35","author":"Bai","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jso.25605","article-title":"Financial toxicity risk among adult patients undergoing cancer surgery in the United States: an analysis of the National Inpatient Sample","volume":"120","author":"Farooq","year":"2019","journal-title":"J Surg Oncol"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"106107","DOI":"10.1016\/j.ijsu.2021.106107","article-title":"Commercial negotiated prices for CMS-specified shoppable surgery services in U.S. hospitals [letter]","volume":"95","author":"Jiang","year":"2021","journal-title":"Int J Surg"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1377\/hlthaff.2012.1263","article-title":"Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis","volume":"32","author":"Ramsey","year":"2013","journal-title":"Health Aff (Millwood)"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1470-2045(21)00345-4","article-title":"Greater price transparency needed for thyroid cancer treatment among US cancer centres","volume":"22","author":"Nierengarten","year":"2021","journal-title":"Lancet Oncol"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/01945998211047146","article-title":"Price transparency and compliance with federal regulation for pediatric tonsillectomy","volume":"167","author":"Ayoub","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref741","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jhealeco.2017.01.007","article-title":"Do hospital mergers reduce costs?","volume":"52","author":"Schmitt","year":"2017","journal-title":"J Health Econ"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1200\/JOP.18.00796","article-title":"Financial costs and burden related to decisions for breast cancer surgery","volume":"15","author":"Greenup","year":"2019","journal-title":"J Oncol Pract"},{"key":"ref891","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jamainternmed.2022.1022","article-title":"Hospital-administered cancer therapy prices for patients with private health insurance","volume":"182","author":"Xiao","year":"2022","journal-title":"JAMA Intern Med"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","article-title":"The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient\u2019s experience","volume":"18","author":"Zafar","year":"2013","journal-title":"Oncologist"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1158\/1055-9965.EPI-19-1534","article-title":"Medical care costs associated with cancer survivorship in the United States","volume":"29","author":"Mariotto","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.euo.2021.02.007","article-title":"Financial toxicity among patients with prostate, bladder, and kidney cancer: a systematic review and call to action","volume":"4","author":"Bhanvadia","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1377\/hlthaff.2020.01535","article-title":"Private equity investments in health care: an overview of hospital and health system leveraged buyouts, 2003-17","volume":"40","author":"Offodile","year":"2021","journal-title":"Health Aff (Millwood)"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/aje\/kwr183","article-title":"Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data","volume":"174","author":"Yelland","year":"2011","journal-title":"Am J Epidemiol"},{"key":"ref961","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/MLR.0b013e31819c95aa","article-title":"Administrative and claims records as sources of health care cost data","volume":"47","author":"Riley","year":"2009","journal-title":"Med Care"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"e1450","DOI":"10.1200\/OP.20.00890","article-title":"Financial toxicity of cancer care: an analysis of financial burden in three distinct health care systems","volume":"17","author":"Parikh","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1377\/hlthaff.2020.01535","article-title":"Private equity investments in health care: an overview of hospital and health system leveraged buyouts, 2003-17","volume":"40","author":"Offodile","year":"2021","journal-title":"Health Aff (Millwood)"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/aje\/kwr183","article-title":"Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data","volume":"174","author":"Yelland","year":"2011","journal-title":"Am J Epidemiol"},{"key":"ref731","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s11606-011-1815-5","article-title":"The association between hospital margins, quality of care, and closure or other change in operating status","volume":"26","author":"Ly","year":"2011","journal-title":"J Gen Intern Med"},{"key":"ref931","doi-asserted-by":"crossref","first-page":"e2137566","DOI":"10.1001\/jamanetworkopen.2021.37566","article-title":"Considering the future of price transparency initiatives-information alone is not sufficient","volume":"4","author":"Emanuel","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jamainternmed.2022.1022","article-title":"Hospital-administered cancer therapy prices for patients with private health insurance","volume":"182","author":"Xiao","year":"2022","journal-title":"JAMA Intern Med"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1377\/hlthaff.2014.1414","article-title":"Extreme markup: the fifty US hospitals with the highest charge-to-cost ratios","volume":"34","author":"Bai","year":"2015","journal-title":"Health Aff (Millwood)"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/0962280211427759","article-title":"Extension of the modified Poisson regression model to prospective studies with correlated binary data","volume":"22","author":"Zou","year":"2013","journal-title":"Stat Methods Med Res"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1245\/s10434-022-11349-y","article-title":"Payer-negotiated prices for breast cancer treatment at NCI-designated cancer treatment centers","volume":"29","author":"Mathew","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/cncr.33299","article-title":"Variations in surgical spending within hospital systems for complex cancer surgery","volume":"127","author":"Diaz","year":"2021","journal-title":"Cancer"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/1556331621991825","article-title":"A review of price transparency policy and evaluation of hospital compliance in orthopedic sports medicine","volume":"17","author":"Schultz","year":"2021","journal-title":"HSS J"},{"key":"ref941","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1001\/jamaoncol.2022.1783","article-title":"Assessment of compliance with Centers for Medicare & Medicaid Services Price Transparency Final Rule","volume":"8","author":"Mathew","year":"2022","journal-title":"JAMA Oncol"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jhealeco.2017.01.007","article-title":"Do hospital mergers reduce costs?","volume":"52","author":"Schmitt","year":"2017","journal-title":"J Health Econ"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/jama.2021.8535","article-title":"Payer-negotiated prices in the diagnosis and management of thyroid cancer in 2021","volume":"326","author":"Xiao","year":"2021","journal-title":"JAMA"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1377\/hlthaff.2021.00541","article-title":"Private equity acquisition and responsiveness to service-line profitability at short-term acute care hospitals","volume":"40","author":"Cerullo","year":"2021","journal-title":"Health Aff (Millwood)"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamasurg.2021.0590","article-title":"Analysis of price transparency for oncologic surgery among National Cancer Institute-designated cancer centers in 2020","volume":"156","author":"Xiao","year":"2021","journal-title":"JAMA Surg"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamaoncol.2019.5690","article-title":"Analysis of price transparency via National Cancer Institute-Designated Cancer Centers\u2019 chargemasters for prostate cancer radiation therapy","volume":"6","author":"Agarwal","year":"2020","journal-title":"JAMA Oncol"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/cncr.33299","article-title":"Variations in surgical spending within hospital systems for complex cancer surgery","volume":"127","author":"Diaz","year":"2021","journal-title":"Cancer"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/01945998211047146","article-title":"Price transparency and compliance with federal regulation for pediatric tonsillectomy","volume":"167","author":"Ayoub","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1200\/JOP.18.00796","article-title":"Financial costs and burden related to decisions for breast cancer surgery","volume":"15","author":"Greenup","year":"2019","journal-title":"J Oncol Pract"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"106107","DOI":"10.1016\/j.ijsu.2021.106107","article-title":"Commercial negotiated prices for CMS-specified shoppable surgery services in U.S. hospitals [letter]","volume":"95","author":"Jiang","year":"2021","journal-title":"Int J Surg"},{"key":"ref981","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1245\/s10434-022-11349-y","article-title":"Payer-negotiated prices for breast cancer treatment at NCI-designated cancer treatment centers","volume":"29","author":"Mathew","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1001\/jama.2017.5702","article-title":"Association between teaching status and mortality in US hospitals","volume":"317","author":"Burke","year":"2017","journal-title":"JAMA"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1475-6773.2010.01082.x","article-title":"Long-term trends in Medicare payments in the last year of life","volume":"45","author":"Riley","year":"2010","journal-title":"Health Serv Res"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1377\/hlthaff.2021.00541","article-title":"Private equity acquisition and responsiveness to service-line profitability at short-term acute care hospitals","volume":"40","author":"Cerullo","year":"2021","journal-title":"Health Aff (Millwood)"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1470-2045(21)00345-4","article-title":"Greater price transparency needed for thyroid cancer treatment among US cancer centres","volume":"22","author":"Nierengarten","year":"2021","journal-title":"Lancet Oncol"},{"key":"ref871","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1377\/hlthaff.2015.1193","article-title":"A more detailed understanding of factors associated with hospital Profitability","volume":"35","author":"Bai","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","article-title":"The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient\u2019s experience","volume":"18","author":"Zafar","year":"2013","journal-title":"Oncologist"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"e1450","DOI":"10.1200\/OP.20.00890","article-title":"Financial toxicity of cancer care: an analysis of financial burden in three distinct health care systems","volume":"17","author":"Parikh","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"ref881","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1377\/hlthaff.2014.1414","article-title":"Extreme markup: the fifty US hospitals with the highest charge-to-cost ratios","volume":"34","author":"Bai","year":"2015","journal-title":"Health Aff (Millwood)"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1001\/jamaoncol.2022.1783","article-title":"Assessment of compliance with Centers for Medicare & Medicaid Services Price Transparency Final Rule","volume":"8","author":"Mathew","year":"2022","journal-title":"JAMA Oncol"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jamaoncol.2021.4979","article-title":"Compliance with price transparency rules at US National Cancer Institute-Designated cancer centers","volume":"7","author":"Chino","year":"2021","journal-title":"JAMA Oncol"},{"key":"ref921","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1158\/1055-9965.EPI-19-1534","article-title":"Medical care costs associated with cancer survivorship in the United States","volume":"29","author":"Mariotto","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jamaoncol.2021.4979","article-title":"Compliance with price transparency rules at US National Cancer Institute-Designated cancer centers","volume":"7","author":"Chino","year":"2021","journal-title":"JAMA Oncol"},{"key":"ref971","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jama.2020.19759","article-title":"The COVID-19 pandemic and the $16 trillion virus","volume":"324","author":"Cutler","year":"2020","journal-title":"JAMA"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1001\/jamainternmed.2021.2531","article-title":"Early hospital compliance with federal requirements for price transparency","volume":"181","author":"Gondi","year":"2021","journal-title":"JAMA Intern Med"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1001\/jamainternmed.2021.2531","article-title":"Early hospital compliance with federal requirements for price transparency","volume":"181","author":"Gondi","year":"2021","journal-title":"JAMA Intern Med"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1001\/jama.2021.4640","article-title":"Price transparency\u2014promise and peril","volume":"325","author":"Glied","year":"2021","journal-title":"JAMA"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"e2110109","DOI":"10.1001\/jamanetworkopen.2021.10109","article-title":"Transparency, accessibility, and variability of US hospital price data","volume":"4","author":"Haque","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1377\/hlthaff.2012.1263","article-title":"Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis","volume":"32","author":"Ramsey","year":"2013","journal-title":"Health Aff (Millwood)"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jama.2020.19759","article-title":"The COVID-19 pandemic and the $16 trillion virus","volume":"324","author":"Cutler","year":"2020","journal-title":"JAMA"},{"key":"ref851","article-title":"Factors associated with compliance to the hospital price transparency final rule: a national landscape study","author":"Jiang","journal-title":"J Gen Intern Med"}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/20\/11\/article-p1215.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/20\/11\/article-p1215.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T18:04:56Z","timestamp":1668189896000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/20\/11\/article-p1215.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":78,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2022.7057","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}